Serum amyloid P-component levels in patients with malignancy

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• The P component of amyloid, serum amyloid P (SAP), is homologous to C-reactive protein (CRP).
• SAP is not an acute-phase reactant in humans but is in mice, where elevated levels are seen with tumor implants.

Purpose of the Study:

• To investigate the association between serum SAP levels and human cancer.
• To determine if SAP levels correlate with disease severity in cancer patients.

Main Methods:

• Serum samples were collected from patients with breast and colon carcinoma, as well as healthy individuals.
• Serum SAP concentrations were measured and compared between groups.
• Correlation analysis was performed between SAP levels and disease severity in breast cancer patients.

Main Results:

• Patients with breast carcinoma exhibited significantly increased serum SAP concentrations compared to healthy individuals.
• In breast cancer patients, SAP levels positively correlated with the severity of the disease.
• Serum SAP levels in patients with colon carcinoma did not differ from those in healthy individuals.

Conclusions:

• Elevated serum SAP levels are associated with breast carcinoma and correlate with disease severity.
• SAP may serve as a potential biomarker for breast cancer.
• The lack of association in colon cancer suggests tissue-specific roles or differential regulation of SAP in human malignancies.